|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Espenel S, Garcia MA, Trone JC, Guillaume
E, Harris A, Rehailia-Blanchard A, He MY, Ouni S, Vallard A,
Rancoule C, et al: From IB2 to IIIB locally advanced cervical
cancers: report of a ten-year experience. Radiat Oncol. 13:162018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Robin TP, Amini A, Schefter TE, Behbakht K
and Fisher CM: Disparities in standard of care treatment and
associated survival decrement in patients with locally advanced
cervical cancer. Gynecol Oncol. 143:319–325. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Koh WJ, Abu-Rustum NR, Bean S, Bradley K,
Campos SM, Cho KR, Chon HS, Chu C, Clark R, Cohn D, et al: Cervical
cancer, Version 3.2019, NCCN clinical practice guidelines in
oncology. J Natl Compr Canc Netw. 17:64–84. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He Y, Han SB, Liu Y, Zhang JJ and Wu YM:
Role of APOA1 in the resistance to platinum-based chemotherapy in
squamous cervical cancer. BMC Cancer. 22:4112022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
International Agency for Research on
Cancer I, organizador, . IARC monographs on the evaluation of
carcinogenic risks to humans. 90. Human papillomaviruses: This
publication represents the views and expert opinions of an IARC
Working Group on the Evaluation of Carcinogenic Risks to Humans
which met in Lyon, 15–22 February 2005. IARC; Lyon: pp.
pp6702007
|
|
7
|
Da Silva MLR, De Albuquerque BHDR, Allyrio
TADMF, De Almeida VD, Cobucci RNDO, Bezerra FL, Andrade VS, Lanza
DCF, De Azevedo JCV, De Araújo JMG and Fernandes JV: The role of
HPV-induced epigenetic changes in cervical carcinogenesis (Review).
Biomed Rep. 15:602021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hanahan D: Hallmarks of Cancer: New
dimensions. Cancer Discov. 12:31–46. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang J and Chen L: The role of miRNAs in
the invasion and metastasis of cervical cancer. Biosci Rep.
39:BSR201813772019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gao C, Zhou C, Zhuang J, Liu L, Liu C, Li
H, Liu G, Wei J and Sun C: MicroRNA expression in cervical cancer:
Novel diagnostic and prognostic biomarkers. J Cell Biochem.
119:7080–7090. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Siomi H and Siomi MC: Posttranscriptional
regulation of microRNA biogenesis in animals. Mol Cell. 38:323–332.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ardekani AM and Naeini MM: The Role of
MicroRNAs in human diseases. Avicenna J Med Biotechnol. 2:161–179.
2010.PubMed/NCBI
|
|
13
|
Causin RL, de Freitas AJA, Trovo Hidalgo
Filho CM, dos Reis R, Reis RM and Marques MMC: A systematic review
of MicroRNAs involved in cervical cancer progression. Cells.
10:6682021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kovall RA, Gebelein B, Sprinzak D and
Kopan R: The canonical notch signaling pathway: Structural and
biochemical insights into shape, sugar, and force. Dev Cell.
41:228–241. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bray SJ: Notch signalling in context. Nat
Rev Mol Cell Biol. 17:722–735. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Penton AL, Leonard LD and Spinner NB:
Notch signaling in human development and disease. Semin Cell Dev
Biol. 23:450–457. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Capaccione KM and Pine SR: The Notch
signaling pathway as a mediator of tumor survival. Carcinogenesis.
34:1420–1430. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Briot A and Iruela-Arispe ML: Blockade of
specific NOTCH ligands: A new promising approach in cancer therapy.
Cancer Discov. 5:112–114. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Khelil M, Griffin H, Bleeker MCG,
Steenbergen RDM, Zheng K, Saunders-Wood T, Samuels S, Rotman J, Vos
W, van den Akker BE, et al: Delta-like ligand-notch1 signaling is
selectively modulated by HPV16 E6 to promote squamous cell
proliferation and correlates with cervical cancer prognosis. Cancer
Res. 81:1909–1921. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Causin RL, da Silva LS, Evangelista AF,
Leal LF, Souza KCB, Pessôa-Pereira D, Matsushita GM, Reis RM,
Fregnani JHTG and Marques MMC: MicroRNA biomarkers of high-grade
cervical intraepithelial neoplasia in liquid biopsy. Biomed Res
Int. 2021:66509662021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He L, Wang HY, Zhang L, Huang L, Li JD,
Xiong Y, Zhang MY, Jia WH, Yun JP, Luo RZ and Zheng M: Prognostic
significance of low DICER expression regulated by miR-130a in
cervical cancer. Cell Death Dis. 5:e1205. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fan Q, Huang T, Sun X, Yang X, Wang J, Liu
Y, Ni T, Gu S, Li Y and Wang Y: miR-130a-3p promotes cell
proliferation and invasion by targeting estrogen receptor α and
androgen receptor in cervical cancer. Exp Ther Med. 21:4142021.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rosa MN, Evangelista AF, Leal LF, De
Oliveira CM, Silva VAO, Munari CC, Munari FF, Matsushita GM, Dos
Reis R, Andrade CE, et al: Establishment, molecular and biological
characterization of HCB-514: A novel human cervical cancer cell
line. Sci Rep. 9:19132019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Silva-Oliveira RJ, Silva VAO, Martinho O,
Cruvinel-Carloni A, Melendez ME, Rosa MN, de Paula FE, de Souza
Viana L, Carvalho AL and Reis RM: Cytotoxicity of allitinib, an
irreversible anti-EGFR agent, in a large panel of human
cancer-derived cell lines: KRAS mutation status as a predictive
biomarker. Cell Oncol (Dordr). 39:253–263. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
miRCURY LNA miRNA Inhibitors and Power
Inhibitors. [Citado 9 de fevereiro de 2023]. Disponível em.
https://www.qiagen.com/us/products/discovery-and-translational-research/functional-and-cell-analysis/mirna-functional-anal-sis/mircury-lna-mirna-inhibitors/mircury-lna-mirna-inhibitors?catno=339126
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Causin RL, Pessôa-Pereira D, Souza KCB,
Evangelista AF, Reis RMV, Fregnani JHTG and Marques MMC:
Identification and performance evaluation of housekeeping genes for
microRNA expression normalization by reverse
transcription-quantitative PCR using liquid-based cervical cytology
samples. Oncol Lett. 18:4753–4761. 2019.PubMed/NCBI
|
|
29
|
Geissmann Q: OpenCFU, a new free and
open-source software to count cell colonies and other circular
objects. PLoS One. 8:e540722013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hu Y, Sun X, Mao C, Guo G, Ye S, Xu J, Zou
R, Chen J, Wang L, Duan P and Xue X: Upregulation of long noncoding
RNA TUG1 promotes cervical cancer cell proliferation and migration.
Cancer Med. 6:471–482. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yew TL, Hung YT, Li HY, Chen HW, Chen LL,
Tsai KS, Chiou SH, Chao KC, Huang TF, Chen HL and Hung SC:
Enhancement of wound healing by human multipotent stromal cell
conditioned medium: The paracrine factors and p38 MAPK activation.
Cell Transplant. 20:693–706. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Martinho O, Silva-Oliveira R,
Miranda-Gonçalves V, Clara C, Almeida JR, Carvalho AL, Barata JT
and Reis RM: In vitro and in vivo analysis of RTK inhibitor
efficacy and identification of its novel targets in glioblastomas.
Transl Oncol. 6:187–196. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
de Andrade DAP, da Silva LS, Laus AC, de
Lima MA, Berardinelli GN, da Silva VD, Matsushita GM, Bonatelli M,
da Silva ALV, Evangelista AF, et al: A 4-Gene signature associated
with recurrence in low- and intermediate-risk endometrial cancer.
Front Oncol. 11:7292192021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tokar T, Pastrello C, Rossos AEM, Abovsky
M, Hauschild AC, Tsay M, Lu R and Jurisica I: mirDIP
4.1-integrative database of human microRNA target predictions.
Nucleic Acids Res. 46:D360–D370. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tang Z, Kang B, Li C, Chen T and Zhang Z:
GEPIA2: An enhanced web server for large-scale expression profiling
and interactive analysis. Nucleic Acids Res. 47:W556–W560. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Park SJ, Yoon BH, Kim SK and Kim SY:
GENT2: An updated gene expression database for normal and tumor
tissues. BMC Medical Genomics. 12 (Suppl 5):S1012019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–1550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mootha VK, Lindgren CM, Eriksson KF,
Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E,
Ridderstråle M, Laurila E, et al: PGC-1alpha-responsive genes
involved in oxidative phosphorylation are coordinately
downregulated in human diabetes. Nat Genet. 34:267–273. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liberzon A, Subramanian A, Pinchback R,
Thorvaldsdóttir H, Tamayo P and Mesirov JP: Molecular signatures
database (MSigDB) 3.0. Bioinformatics. 27:1739–1740. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liberzon A, Birger C, Thorvaldsdóttir H,
Ghandi M, Mesirov JP and Tamayo P: The molecular signatures
database (MSigDB) hallmark gene set collection. Cell Syst.
1:417–425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
da Zhang H, Jiang LH, Sun DW, Li J and Ji
ZL: The role of miR-130a in cancer. Breast Cancer. 24:521–527.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang M, Wang X and Liu W: MicroRNA-130a-3p
promotes the proliferation and inhibits the apoptosis of cervical
cancer cells via negative regulation of RUNX3. Mol Med Rep.
22:2990–3000. 2020.PubMed/NCBI
|
|
45
|
Zhao X, Jin X, Zhang Q, Liu R, Luo H, Yang
Z, Geng Y, Feng S, Li C, Wang L, et al: Silencing of the lncRNA H19
enhances sensitivity to X-ray and carbon-ions through the
miR-130a-3p /WNK3 signaling axis in NSCLC cells. Cancer Cell Int.
21:6442021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hu W, Zheng X, Liu J, Zhang M, Liang Y and
Song M: MicroRNA MiR-130a-3p promotes gastric cancer by targeting
Glucosaminyl N-acetyl transferase 4 (GCNT4) to regulate the
TGF-β1/SMAD3 pathway. Bioengineered. 12:11634–1147. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Huang J, Zhao M, Hu H, Wang J, Ang L and
Zheng L: MicroRNA-130a reduces drug resistance in breast cancer.
Int J Clin Exp Pathol. 12:2699–2705. 2019.PubMed/NCBI
|
|
48
|
Liu Y, Li Y, Wang R, Qin S, Liu J, Su F,
Yang Y, Zhao F, Wang Z and Wu Q: MiR-130a-3p regulates cell
migration and invasion via inhibition of Smad4 in gemcitabine
resistant hepatoma cells. J Exp Clin Cancer Res. 35:192016.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yu F, Fan X, Chen B, Dong P and Zheng J:
Activation of hepatic stellate cells is inhibited by
microRNA-378a-3p via Wnt10a. Cell Physiol Biochem. 39:2409–2420.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhou H, Tang H, Li N, Chen H, Chen X, Gu
L, Zhang L, Tian G and Tao D: MicroRNA-361-3p inhibit the
progression of lymphoma by the Wnt/β-catenin signaling pathway.
Cancer Manag Res. 12:12375–12384. 2020. View Article : Google Scholar : PubMed/NCBI
|
